Compared to NR1-2A and NR1-2B subtypes, NR1-2C and NR1-2D subtypes have a higher probability of being antagonized by uncompetitive NMDAR channel blockers at concentrations potentially therapeutic for MDD and other disorders [24]. This evidence concerns the gene GRIN1 and major depressive disorder.